1Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery [J]. JAMA,2007,297(5) : 471 -479.
2Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case - control comparison of aprotinin and tranexamic acid in high - transfusion - risk cardiac surgery [ J ]. Transfusion, 2006, 46(3) : 327 -338.
3Porte RJ, Leebeek FW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery [ J ]. Drugs,2002, 62(15) : 2193 -2211.
4Slaughter TF, Faghih F, Greenberg CS, et al. The effects of epsilon - aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery [ J]. Anesth Analg, 1997,85 (6) : 1221 - 1226.
5Kikura M, Levy JH, Tanaka KA, et al. A double - blind, placebo - controlled trial of epsilon - aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery [ J]. J Am Coll Surg,2006, 202(2) : 216 -222.
6FanashaweMP, Shore -Lesserson L, Reich DL. Two cases of fatal thmmbosisafteraminocaproic acid therapy and deep hypothermic circulatory arrest [ J]. Anesthesiology, 2001,95 ( 6 ): 1525 -1527.
7Winter SS, Chaffee S, Kahler SG, et al. epsilon - Aminocaproic acid -associated myopathy in a child [ J]. J Pediatr Hematol Oncol,1995, 17(1) : 53 -55.
8Laupacis A, Fergusson D. Drags to minimize perioperative blood loss in cardiac surgery: meta - analyses using perioperative blood transfusion as the outcome. The International Study of Perioperative Transfusion ( ISPOT ) Investigators [ J ]. Anesth Analg,1997,85(6) : 1258 - 1267.
9Munoz JJ, Birkmeyer N J, Birkmeyer JD, et al. Is epsilon - aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis [J]. Circulation, 1999,99(1) : 81 -89.
10Umscheid CA, Kohl BA, Williams K. Antifibrinolytic use in adult cardiac surgery [ J]. Curr Opin Hematol,2007, 14(5) : 455 - 467.
3Punjabi PP, Wyse RK, Taylor KM. Role of aprotinin in the management of patients during and after cardiac surgery. Expert Opin Pharmacother, 2000,1 : 1353-1365.
4Sato Y, Ishikawa S, Otaki A, et al. Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury. Jpn J Thorac Cardiovasc Surg, 2000, 48:428-434.
5Karaca P, Konuralp C, Enc Y, et al. Cardioprotective effect of aprotinin on myocardial ischemia/reperfusion injury during cardiopulmonary bypass. Circ J, 2006,70:1432-1436.
6Harig F, Feyrer R, Mahmoud FO, et al. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin. Thorac Cardiovasc Surg, 1999,47:111-118.
7Oliver WC Jr, Fass DN, Nuttall GA, et al. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg, 2004 , 127 : 1670-1677.
8Martin Burcio S, Valino Gonzalez J, Dominguez F, et al. Use of aprotinin during pediatric heart surgery . Rev Esp Anesthesiol Reanim, 2001,48:212-246.
9Arnold DM, Fergusson DA, Chan AK, et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg, 2006,102: 731-737.
1Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA, 2007,297 ( 5 ) : 471-479.
2Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score casecontrol comparison of aprotinin and tranexamic acid in hightransfusion-risk cardiac surgery. Transfusion, 2006,46 ( 3 ) : 327- 338.
3Fergusson DA,Hebert PC,Mazer CD,et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med, 2008,358(22) :2319-2331.
4Lemer AB. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation [J]. J Cardiothorae Vase Anesth, 2006,20(6) : 888-890.
5Dalman A, Sabate A, Acosta F, et al. Tranexamie acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation [J]. Anesth Analg, 2000,91 ( 1 ) : 29-34.
6Dietrich W. Aprotinin: 1 year on [J]. Curt Opin Anaesthesiol, 2009,22( 1 ) : 121-127.
7Kim EH, Song SH, Kim GS, et al. Evaluation of "flat-line" thromboelastography after reperfusion during liver transplantation [J]. Transplant Proc, 2015,47(2) :457-459.
8Draxler DF, Medcalf RL. The fibrinolytic system-more thanfibrinolysis ? [ J ]. Transfus Med Rev, 2015,29 (2) : 102-109.
9Xie J, Lenke LG, Li T, et al. Preliminary investigation of high- dse tranexaraic acid f ctrolling intraoperative blood loss in patients undergoing spine correction surgery [J]. Spine J, 2015, 15 (4) : 647 -654.
10Dalmau A, Sabate A, Acosta F, et al. Comparative study of antifibrinolytic drugs in orthotopic liver transplantation [J]. Transplant Proc, 1999,31 (6) : 2361-2362.
